Navigation Links
Hormone therapy may affect heart attack severity in women

Recent studies undertaken at Wake Forest University Baptist Medical Center researcher and colleagues, showed promising signs after research in monkeys suggested //that the type of progestin in hormonal therapy could in fact affect heart attack severity.

At an annual meeting of the North American Menopause Society in Washington, D.C. today, Dr. J. Koudy Williams who is the lead investigator from Wake Forest Baptist formally announced, “One type of hormone therapy limited heart muscle damage to only 5 percent while another resulted in permanent damage to 35 percent of muscle. If we can learn more about this mechanism we might be able to identify better hormone therapies for postmenopausal women."

Hormone therapy had been prescribed for several years as a way to prevent heart vessel disease in women. However after several research studies, including the Women's Health Initiative, it was found that combination therapy (estrogen plus progestin) increased the risk of both a first and second heart attack in older women. These studies though holistic in itself did not look at the amount of heart damage that occurs if a postmenopausal woman has a heart attack. Dr Williams went on to say that it is gravely impotent to know this information as many women take combination therapy drugs for menopausal symptoms or to protect their bones even though the drugs are no longer recommended to prevent heart disease.

In a study of postmenopausal monkeys, Williams and colleagues compared the protestin in Prempro?, the most widely prescribed hormone therapy, with the progestin in Femhrt.

One group of monkeys where given estrogen and the Femhrt progestin, while a second group where given estrogen and the Prempro progestin and a third group where not given any hormone therapy. The monkey were given these drugs for a period of one year in the doses equivalent to those prescribed to women.

The researchers then measured the
'"/>




Page: 1 2

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. Hormone replacement Therapy a headache
3. Ovarian cancer in relationship with Hormone therapy
4. Hormone contraceptives lead to bone problems
5. Hormone treatment helps obese people slim down
6. Hormone Deficiency Results In Miscarriage
7. Hormones Linked To Migraines
8. Hormone replacement therapy helps women
9. Decrease of Hunger Hormone after Obesity Surgery
10. Possible benefits of Hormone Replacement Therapy
11. Hormone replacement therapy improves sexual function
Post Your Comments:
(Date:10/6/2008)...arnCDHC, a Web-based resource designed to engage a...are (CDHC) options including Health Savings Accoun...d Flexible Spending Accounts (FSAs), has partnered...prise level services in concert with its existing ...el. , MINNEAPOLIS (Busin...
(Date:10/6/2008)...swire-FirstCall/ -- Volcano Corporation,(Nasdaq: ... and sales of,products for the diagnosis and treat...day announced the relocation of its corporate head... to San Diego. The new corporate,headquarters is l...now,houses corporate executives, marketing, financ...
(Date:10/6/2008)...y personnel and their family members can take,anon...nts, BOSTON, Oct. 6 /PRNewswire-USNewswire/ -- Mi...ers and their families that are unique and,difficu...tances matters get,worse and one problem can trigg...wise to check things out to see what is really hap...
(Date:10/6/2008)... /PRNewswire/ -- Today, PARI Pharma GmbH will,unve...y that uses single,dose ampoules to control medica...roprietary, unit-dose ampoule that is required to ...ow Technology meets an unmet need by,reducing the ... device,simplifying filling procedures, improving...
Breaking Medicine News(10 mins):Health News: LearnCDHC Bridges Education Gap on Consumer Directed Healthcare : Interactive Web resource engages and educates consumers about consumer-directed healthcare 2Health News: LearnCDHC Bridges Education Gap on Consumer Directed Healthcare : Interactive Web resource engages and educates consumers about consumer-directed healthcare 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 4Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference 2
...weight and obese individuals, the incidence of ast...e of normal weight, according to a meta-analysis o... patients.The results appear in the first issue fo...f Respiratory and Critical Care Medicine, publishe...
...led by researchers at the Keck School of Medicine ... Harvard Medical School has identified// seven gen...ople but not others—that predict risk for prostate... risk factors are clustered in a single region of ...
...first time ever, a team of Toronto researchers are... //to screen high-risk pregnant mothers for placen..., most high-risk mothers can be reassured that the...o they can expect a healthy pregnancy. The tests a...
...osterone levels of healthy men decline as they get...crease with age, //objectively measured difference...can affect his level of testosterone in the mornin...he April 1st issue of the journal SLEEP. The stu...
Other Medicine News:Health News:Asthma Incidence Shows a 50 Percent Increase in Fat People 2Health News:Study Identifies Multiple Genetic Risk Factors for Prostate Cancer 2Health News:New Placenta Screening for High-risk Pregnancies 2Health News:Sleep Quantity Affects Morning Testosterone Levels in Older Men 2
(Date:10/6/2008)...., Oct. 6 /- Pharmasset, In...ith, Ph.D., is joining the,Company as Vice Preside...ons. Dr. Smith will be responsible for all investo...Chief Financial Officer Kurt,Leutzinger., Most re...Biotechnology,Analyst at JPMorgan Securities, and ...
(Date:10/6/2008)...deo clips feature children, parents discussing cli...HESDA, Md., Oct. 6 /PRNewswire-USNewswire/ -- From...h in children saves lives and improves their,healt... Institutes of,Health (NIH), "Children and Clinica....nhlbi.nih.gov ), offers parents and health,care p...
(Date:10/6/2008)...NG, Pa., Oct. 6 /- Genaera,...rom its second Phase 1,clinical trial of trodusque... the treatment of type 2 diabetes and obesity. MSI...olecular target that controls the function,of both...ose and decrease,appetite. In the study, MSI-1436 ...
(Date:10/6/2008)...cedure May Eliminate 6 Weeks of Radiation Therapy ...er the Internet Wednesday, October 22, 2008, 3 ...rehealth , HAMPTON, Va., Oct. 6 / Qu...s diagnosed with breast cancer in May. Would she h...out radiation or chemotherapy?, , To view the Mu...
Breaking Medicine Technology:Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Seduce with Mousse Replens Introduces Intimate Options 3A First Personal Lubricant Mousse in Canada 4137 1Seduce with Mousse Replens Introduces Intimate Options 3A First Personal Lubricant Mousse in Canada 4137 2Finesse Introduces TruFluor 28TM 29 DO a Single Use Optical Dissolved Oxygen Sensor and Transmitter 4136 1Finesse Introduces TruFluor 28TM 29 DO a Single Use Optical Dissolved Oxygen Sensor and Transmitter 4136 2HIV Vaccine Funding 3A Enough is Enough Says AHF in Baltimore Sun 14917 1HIV Vaccine Funding 3A Enough is Enough Says AHF in Baltimore Sun 14917 2HIV Vaccine Funding 3A Enough is Enough Says AHF in Baltimore Sun 14917 3HIV Vaccine Funding 3A Enough is Enough Says AHF in Baltimore Sun 14917 4Yerkes researchers identify language feature unique to human brain 2586 1
...f efficacy trends from ongoing phase I/II trial,of...ntation in,press conference , MARTINSRIED, Germany...(Frankfurt, Prime Standard: MDG) announces that a ...iGene,s cancer killing,virus will be presented in ...r Medical Oncology. Out of more than 300 posters a...
...07 /PRNewswire-FirstCall/ -- Advanced Life,Science...st a,conference call and live webcast at 10:00 am ... Trial CL-06, the first of two pivotal,Phase 3 cli...ectiveness of cethromycin, a novel once-a-day anti...eumonia (CAP). , Conference Call Details: , The co...
Other Medicine Technology:European Society for Medical Oncology (ESMO) Presents Data from the,Clinical Trial of MediGene's Cancer-Killing Virus in Press,Conference 2Advanced Life Sciences to Host Conference Call to Discuss Data From,Cethromycin's First of Two Phase 3 Pneumonia Trials 2
The Compass Commander series is engineered to provide the discriminating neurosurgeon with the same capabilities offered within the commander plus+, all in a smaller, lower-cost package.
Used to negotiate tortuous vessels.
Used for vascular and non-vascular applications. Tapered fixed core construction provides gradual transition to a flexible,tip. Supplied sterile in peel-open packages. Intended for one-time use.
Merit Medical is pleased to offer diagnostic guide wires for angiographic procedures. The pre-coated, high-performance, InQwire guide wire provides a consistent, uniform coating which is very lubrici
Medicine Products: